BamSEC and AlphaSense Join Forces
Learn More

Karyopharm Therapeutics Inc. – Indentures

Formerly NASDAQ: KPTI
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 10-Q 34 pages Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 10-Q 17 pages Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.4
from S-3 8 pages Form of Subordinated Note
12/34/56
EX-4.3
from S-3 8 pages Form of Senior Note
12/34/56
EX-4.4
from S-3 22 pages Registration Rights Agreement
12/34/56
EX-4.2
from S-3 16 pages Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.2
from S-3 61 pages Karyopharm Therapeutics Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.1
from S-3 59 pages Karyopharm Therapeutics Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.1
from S-3 33 pages Warrant to Purchase Common Stock
12/34/56
EX-4.2
from 8-K 17 pages Form of Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 16 pages Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.9
from 10-K 4 pages Description of Securities Registered Under Section 12 of the Exchange Act
12/34/56
EX-4.6
from 8-K 17 pages Pre-Funded Warrant to Purchase Common Stock Karyopharm Therapeutics Inc
12/34/56
EX-4.5
from 8-K 17 pages Common Stock Purchase Warrant Karyopharm Therapeutics Inc
12/34/56
EX-4.4
from 8-K 18 pages Common Stock Purchase Warrant Karyopharm Therapeutics Inc
12/34/56
EX-4.3
from 8-K 36 pages Common Stock Purchase Warrant Karyopharm Therapeutics Inc
12/34/56
EX-4.2
from 8-K 167 pages Karyopharm Therapeutics Inc., as Issuer the Guarantors Party Hereto, and Wilmington Savings Fund Society, Fsb, as Trustee Indenture Dated as of October 10, 2025 9.00% Convertible Senior Notes Due 2029
12/34/56
EX-4.1
from 8-K 171 pages Karyopharm Therapeutics Inc., as Issuer the Guarantors Party Hereto, and Wilmington Savings Fund Society, Fsb, as Trustee Indenture Dated as of October 10, 2025 9.00% Convertible Senior Notes Due 2028
12/34/56
EX-4.2
from 10-K 4 pages Description of Securities Registered Under Section 12 of the Exchange Act
12/34/56
EX-4.2
from 8-K 30 pages Form of Common Stock Purchase Warrant Karyopharm Therapeutics Inc
12/34/56